Skip to contentClarengateINTELLIGENCE
Coverage & freshness About Clarengate
Companies/10167668

Achilles Therapeutics UK Limited

Private Limited Company · Birmingham

Creditors Voluntary Liquidation (CVL)United KingdomIncorporated 2016Private Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

No processed account filings

No processed accounts are available in our records.

Registered details

10167668
Status
Liquidation
Type
Private Limited Company
Incorporated
2016-05-06
Jurisdiction
—
Registered office
C/O TENEO FINANCIAL ADVISORY LIMITED, THE COLMORE BUILDING, BIRMINGHAM, B4 6AT

Classification

1 SIC codes
23112

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

0 SH01-derived rounds

No reconstructed allotment rounds.

Research and innovation

6 matched grants
Characterising the metabolic requirements of the newly-identified DC3 subsetActive
MRC · Studentship · 2022-09-30 – 2026-09-29 · with 1 other participant
£0
whole project
Queen Mary University Of LondonleadAchilles Therapeutics UK Limited
Smart MAnufactuRing for Autologous Cell ThERapies enabled by innovative biomonitoring technologies and advanced process controlLead
Innovate UK · EU-Funded · 2022-09-01 – 2025-08-31
£1,220,430
awarded
Smart MAnufactuRing for Autologous Cell ThERapies enabled by innovative biomonitoring technologies and advanced process controlLead
Horizon Europe Guarantee · EU-Funded · 2022-08-31 – 2025-08-30
£1,220,430
whole project
Smart MAnufactuRing for Autologous Cell ThERapies enabled by innovative biomonitoring technologies and advanced process control
Horizon Europe Guarantee · EU-Funded · 2022-08-31 – 2025-08-30
£1,220,430
whole project
Northern Alliance ATTC
Innovate UK · Centres · 2021-04-01 – 2022-03-31 · with 20 other participants
£43,530
awarded
The Newcastle upon Tyne Hospitals NHS Foundation Trustlead£566,226
Leeds Teaching Hospitals NHS Trust£301,910
Autolus Limited£247,831
University of Edinburgh£232,927
Scottish National Blood Transfusion Service£148,496
Greater Glasgow Health Board£145,285
Alcyomics Limited£122,284
Newcastle University£121,726
Achilles Therapeutics UK Limited£43,530
Global Life Sciences Solutions Operations UK Ltd£40,366
Vascversa Ltd£35,560
Thermo Electron Limited£22,500
Health Innovation North East And North Cumbria Limited£21,900
NHS Blood and Transplant£14,274
Trakcel Limited£8,838
World Courier Management Limited£3,608
NHS Lothian£3,553
Datatrial Limited£0
Phion Therapeutics Ltd£0
Sheffield Teaching Hospitals NHS Foundation Trust£0
University of Glasgow£0
Northern Alliance ATTC
ISCF · Centres · 2021-03-31 – 2022-03-30 · with 20 other participants
£2,080,814
whole project
The Newcastle Upon Tyne Hospitals NHS Foundation TrustleadAchilles Therapeutics UK LimitedAlcyomics LimitedAutolus LimitedDatatrial LimitedGlobal Life Sciences Solutions Operations UK LtdGreater Glasgow Health BoardHealth Innovation North East And North Cumbria LimitedLeeds Teaching Hospitals NHS TrustNewcastle UniversityNHS Blood And TransplantNHS LothianPhion Therapeutics LtdScottish National Blood Transfusion ServiceSheffield Teaching Hospitals NHS Foundation TrustThermo Electron LimitedTrakcel LimitedUniversity Of EdinburghUniversity Of GlasgowVascversa LtdWorld Courier Management Limited